Amy Harlow

Primary and Secondary Kinase Genotypes Correlate With the Biological and Clinical Activity of Sunitinib in Imatinib-Resistant Gastrointestinal Stromal Tumor

Michael C. Heinrich, Robert G. Maki, Christopher L. Corless et al. · Journal of Clinical Oncology · 2008 · 799 citations · Full text

<i>KIT</i> Gene Mutations and Copy Number in Melanoma Subtypes

Carol Beadling, Erick Jacobson‐Dunlop, F. Stephen Hodi et al. · Clinical Cancer Research · 2008 · 632 citations · Full text

Mutations in KIT and RAS are frequent events in pediatric core-binding factor acute myeloid leukemia

Bianca F. Goemans, Ch. M. Zwaan, Mitchell Miller et al. · Leukemia · 2005 · 239 citations · Full text

Hematological Malignancy, Chromatin, Pediatric Hematology +8

Phase II, Open-Label Study Evaluating the Activity of Imatinib in Treating Life-Threatening Malignancies Known to Be Associated with Imatinib-Sensitive Tyrosine Kinases

Michael C. Heinrich, Heikki Joensuu, George D. Demetri et al. · Clinical Cancer Research · 2008 · 212 citations

Pediatric <i>KIT</i> –Wild-Type and Platelet-Derived Growth Factor Receptor α–Wild-Type Gastrointestinal Stromal Tumors Share KIT Activation but not Mechanisms of Genetic Progression with Adult Gastrointestinal Stromal Tumors

Katherine A. Janeway, Bernadette Liegl, Amy Harlow et al. · Cancer Research · 2007 · 169 citations · Full text